Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthma
- 1 September 2015
- journal article
- Published by Elsevier BV in American Journal of Otolaryngology
- Vol. 36 (5), 672-677
- https://doi.org/10.1016/j.amjoto.2015.05.008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Allergic bronchopulmonary aspergillosis and omalizumabAllergy, 2011
- Efficacy of omalizumab in the treatment of nasal polypsThorax, 2010
- Omalizumab for treatment of ABPA exacerbations in CF patientsPediatric Pulmonology, 2009
- Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti‐IgE antibody (omalizumab)Pediatric Pulmonology, 2008
- Steroid‐sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosisPediatric Pulmonology, 2008
- Allergic Fungal Rhinosinusitis: Current Theories and Management StrategiesThe Laryngoscope, 2001
- Rhinosinusitis in severe asthmaJournal of Allergy and Clinical Immunology, 2001
- Eosinophilic Mucin Rhinosinusitis: A Distinct Clinicopathological EntityThe Laryngoscope, 2000
- Diagnostic criteria for allergic fungal sinusitisJournal of Allergy and Clinical Immunology, 1995
- Evidence of ige‐mediated hypersensitivity in allergic fungal sinusitisThe Laryngoscope, 1993